Clinical trial
Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular…
NCT00479050 · Shandong University, Other · Completed
Key facts
| NCT number | NCT00479050 |
|---|---|
| Title | Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm |
| Official title | Phase 1 Study of Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm |
| Acronym | TACE-RFA |
| Lead sponsor | Shandong University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hepatocellular Carcinoma |
| Intervention type | Procedure |
| Interventions | chemoembolization, Radiofrequency ablation |
| Enrollment | 291 |
| Start date | Jan 1, 2001 |
| Completion | Dec 1, 2006 |
| First posted | May 25, 2007 |
| Last update posted | May 25, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: